|
1
|
Brisdelli F, D’Andrea G and Bozzi A:
Resveratrol: a natural polyphenol with multiple chemopreventive
properties. Curr Drug Metab. 10:530–546. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cao Y, Cao R and Brakenhielm E:
Antiangiogenic mechanisms of diet-derived polyphenols. J Nutr
Biochem. 13:380–390. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brakenhielm E, Cao R and Cao Y:
Suppression of angiogenesis, tumor growth, and wound healing by
resveratrol, a natural compound in red wine and grapes. FASEB J.
15:1798–1800. 2001.PubMed/NCBI
|
|
4
|
Aquilano K, Baldelli S, Rotilio G and
Ciriolo MR: Trans-Resveratrol inhibits
H2O2-induced adenocarcinoma gastric cell
proliferation via inactivation of MEK1/2-ERK1/2-c-jun signalling
axis. Biochem Pharmacol. 77:337–347. 2009.PubMed/NCBI
|
|
5
|
Kozuki Y, Miura Y and Yagasaki K:
Resveratrol suppresses hepatoma cell invasion independently of its
anti-proliferative action. Cancer Lett. 167:151–156. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Woo JH, Lim JH, Kim YH, et al: Resveratrol
inhibits phorbol myristate acetate-induced matrix
metalloproteinase-9 expression by inhibiting JNK and PKC delta
signal transduction. Oncogene. 23:1845–1853. 2004. View Article : Google Scholar
|
|
7
|
Sun C, Hu Y, Liu X, et al: Resveratrol
downregulates the constitutional activation of nuclear
factor-kappaB in multiple myeloma cells, leading to suppression of
proliferation and invasion, arrest of cell cycle, and induction of
apoptosis. Cancer Genet Cytogenet. 165:9–19. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Klinge CM, Blankenship KA, Risinger KE, et
al: Resveratrol and estradiol rapidly activate MAPK signaling
through estrogen receptors alpha and beta in endothelial cells. J
Biol Chem. 280:7460–7468. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aziz MH, Kumar R and Ahmad N: Cancer
chemoprevention by resveratrol: in vitro and in vivo
studies and the underlying mechanisms (Review). Int J Oncol.
23:17–28. 2003.PubMed/NCBI
|
|
10
|
Tang FY, Chiang EP and Sun YC: Resveratrol
inhibits heregulin-beta1-mediated matrix metalloproteinase-9
expression and cell invasion in human breast cancer cells. J Nutr
Biochem. 19:287–294. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yilmaz M, Christofori G and Lehembre F:
Distinct mechanisms of tumor invasion and metastasis. Trends Mol
Med. 13:535–541. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Woessner JF Jr: Matrix metalloproteinases
and their inhibitors in connective tissue remodeling. FASEB J.
5:2145–2154. 1991.PubMed/NCBI
|
|
13
|
Hidalgo M and Eckhardt SG: Development of
matrix metalloproteinase inhibitors in cancer therapy. J Natl
Cancer Inst. 93:178–193. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Roach DM, Fitridge RA, Laws PE, Millard
SH, Varelias A and Cowled PA: Up-regulation of MMP-2 and MMP-9
leads to degradation of type IV collagen during skeletal muscle
reperfusion injury; protection by the MMP inhibitor, doxycycline.
Eur J Vasc Endovasc Surg. 23:260–269. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bachmeier BE, Iancu CM, Jochum M and
Nerlich AG: Matrix metalloproteinases in cancer: comparison of
known and novel aspects of their inhibition as a therapeutic
approach. Expert Rev Anticancer Ther. 5:149–163. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee SO, Jeong YJ, Im HG, Kim CH, Chang YC
and Lee IS: Silibinin suppresses PMA-induced MMP-9 expression by
blocking the AP-1 activation via MAPK signaling pathways in MCF-7
human breast carcinoma cells. Biochem Biophys Res Commun.
354:165–171. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dhillon AS, Hagan S, Rath O and Kolch W:
MAP kinase signalling pathways in cancer. Oncogene. 26:3279–3290.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bradham C and McClay DR: p38 MAPK in
development and cancer. Cell Cycle. 5:824–828. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee SJ, Kim WJ and Moon SK: Role of the
p38 MAPK signaling pathway in mediating interleukin-28A-induced
migration of UMUC-3 cells. Int J Mol Med. 30:945–952.
2012.PubMed/NCBI
|
|
20
|
Zhang B, Wang X, Cai F, Chen W, Loesch U,
Bitzer J and Zhong XY: Effects of salinomycin on human ovarian
cancer cell line OV2008 are associated with modulating p38 MAPK.
Tumour Biol. July 7–2012.(Epub ahead of print).
|
|
21
|
Foster FM, Traer CJ, Abraham SM and Fry
MJ: The phosphoinositide (PI) 3-kinase family. J Cell Sci.
116:3037–3040. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cotrim CZ, Fabris V, Doria ML, et al:
Estrogen receptor beta growth-inhibitory effects are repressed
through activation of MAPK and PI3K signalling in mammary
epithelial and breast cancer cells. Oncogene. July 2–2012.(Epub
ahead of print).
|
|
23
|
Dineva IK, Zaharieva MM, Konstantinov SM,
Eibl H and Berger MR: Erufosine suppresses breast cancer in vitro
and in vivo for its activity on PI3K, c-Raf and Akt proteins. J
Cancer Res Clin Oncol. June 30–2012.(Epub ahead of print).
|
|
24
|
Park SY, Kim YH, Kim YH and Lee SJ:
Aromatic-turmerone attenuates invasion and expression of MMP-9 and
COX-2 through inhibition of NF-κB activation in TPA-induced breast
cancer cells. J Cell Biochem. June 27–2012.(Epub ahead of
print).
|
|
25
|
Nam KS and Shon YH: Suppression of
metastasis of human breast cancer cells by chitosan
oligosaccharides. J Microbiol Biotechnol. 19:629–633.
2009.PubMed/NCBI
|
|
26
|
Lu N, Ling Y, Gao Y, et al: Endostar
suppresses invasion through downregulating the expression of matrix
metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells. Exp
Biol Med (Maywood). 233:1013–1020. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sato H, Takino T, Okada Y, Cao J,
Shinagawa A, Yamamoto E and Seiki M: A matrix metalloproteinase
expressed on the surface of invasive tumour cells. Nature.
370:61–65. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Khokha R: Suppression of the tumorigenic
and metastatic abilities of murine B16-F10 melanoma cells in vivo
by the overexpression of the tissue inhibitor of the
metalloproteinases-1. J Natl Cancer Inst. 86:299–304. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rosenblum G, Meroueh SO, Kleifeld O, et
al: Structural basis for potent slow binding inhibition of human
matrix metalloproteinase-2 (MMP-2). J Biol Chem. 278:27009–27015.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim ES, Sohn YW and Moon A:
TGF-beta-induced transcriptional activation of MMP-2 is mediated by
activating transcription factor (ATF)2 in human breast epithelial
cells. Cancer Lett. 252:147–156. 2007. View Article : Google Scholar
|
|
31
|
Cohen M, Meisser A, Haenggeli L and
Bischof P: Involvement of MAPK pathway in TNF-alpha-induced MMP-9
expression in human trophoblastic cells. Mol Hum Reprod.
12:225–232. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kajanne R, Miettinen P, Mehlem A, et al:
EGF-R regulates MMP function in fibroblasts through MAPK and AP-1
pathways. J Cell Physiol. 212:489–497. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Westermarck J, Holmström T, Ahonen M, et
al: Enhancement of fibroblast collagenase-1 (MMP-1) gene expression
by tumor promoter okadaic acid is mediated by stress-activated
protein kinases Jun N-terminal kinase and p38. Matrix Biol.
17:547–557. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cho HJ, Kang JH, Kwak JY, et al:
Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9
gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent
mechanisms. Carcinogenesis. 28:1104–1110. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hong IK, Kim YM, Jeoung DI, Kim KC and Lee
H: Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK,
JNK and c-Jun pathways in human melanoma cells. Exp Mol Med.
37:230–239. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang L, Ling Y, Chen Y, et al: Flavonoid
baicalein suppresses adhesion, migration and invasion of MDA-MB-231
human breast cancer cells. Cancer Lett. 297:42–48. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang C, Li Y, Qian ZJ, Lee SH, Li YX and
Kim SK: Dieckol from Ecklonia cava regulates invasion of
human fibrosarcoma cells and modulates MMP-2 and MMP-9 expression
via NF-κB pathway. Evid Based Complement Alternat Med.
2011:1404622011.PubMed/NCBI
|
|
38
|
Chen P, Lu N, Ling Y, et al: Inhibitory
effects of wogonin on the invasion of human breast carcinoma cells
by downregulating the expression and activity of matrix
metalloproteinase-9. Toxicology. 282:122–128. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tang FY, Su YC, Chen NC, Hsieh HS and Chen
KS: Resveratrol inhibits migration and invasion of human
breast-cancer cells. Mol Nutr Food Res. 52:683–691. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Johnson MK and Loo G: Effects of
epigallocatechin gallate and quercetin on oxidative damage to
cellular DNA. Mutat Res. 459:211–218. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu PL, Tsai JR, Charles AL, et al:
Resveratrol inhibits human lung adenocarcinoma cell metastasis by
suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway
and subsequently downregulating expression of matrix
metalloproteinases. Mol Nutr Food Res. 54(Suppl 2): S196–S204.
2010. View Article : Google Scholar
|
|
42
|
Lee SJ and Kim MM: Resveratrol with
antioxidant activity inhibits matrix metalloproteinase via
modulation of SIRT1 in human fibrosarcoma cells. Life Sci.
88:465–472. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Park JS, Kim KM, Kim MH, et al:
Resveratrol inhibits tumor cell adhesion to endothelial cells by
blocking ICAM-1 expression. Anticancer Res. 29:355–362.
2009.PubMed/NCBI
|
|
44
|
Lee MF, Pan MH, Chiou YS, Cheng AC and
Huang H: Resveratrol modulates MED28 (Magicin/EG-1) expression and
inhibits epidermal growth factor (EGF)-induced migration in
MDA-MB-231 human breast cancer cells. J Agric Food Chem.
59:11853–11861. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yar AS, Menevse S and Alp E: The effects
of resveratrol on cyclooxygenase-1 and -2, nuclear factor kappa
beta, matrix metalloproteinase-9, and sirtuin 1 mRNA expression in
hearts of streptozotocin-induced diabetic rats. Genet Mol Res.
10:2962–2975. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Weng CJ, Wu CF, Huang HW, Wu CH, Ho CT and
Yen GC: Evaluation of anti-invasion effect of resveratrol and
related methoxy analogues on human hepatocarcinoma cells. J Agric
Food Chem. 58:2886–2894. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liao PC, Ng LT, Lin LT, Richardson CD,
Wang GH and Lin CC: Resveratrol arrests cell cycle and induces
apoptosis in human hepatocellular carcinoma Huh-7 cells. J Med
Food. 13:1415–1423. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang Z, Li W, Meng X and Jia B:
Resveratrol induces gastric cancer cell apoptosis via reactive
oxygen species, but independent of sirtuin1. Clin Exp Pharmacol
Physiol. 39:227–232. 2012. View Article : Google Scholar : PubMed/NCBI
|
